RBC Capital Increases Target Price on Boston Scientific Corporation (BSX) to $125
Boston Scientific Corporation continues to make headlines in the stock market, capturing investor attention with consistent innovation and a promising growth trajectory. RBC Capital Markets, one of the most respected financial institutions in the investment world, recently raised its target price on Boston Scientific Corporation (BSX) shares to $125, up from $120. This price increase is a strong signal that the company is performing well and is expected to continue its upward trend.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
